| Identification | Back Directory | [Name]
Letermovir | [CAS]
710312-77-9 | [Synonyms]
L-Cysteinamide, N2-(3-mercapto-1-oxopropyl)-L-arginylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide | [Molecular Formula]
C34H47N11O9S2 | [MOL File]
710312-77-9.mol | [Molecular Weight]
817.94 |
| Chemical Properties | Back Directory | [density ]
1.62±0.1 g/cm3(Predicted) | [pka]
4.01±0.10(Predicted) | [Sequence]
{Mpa}-Cys-Arg-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge：Mpa1-Cys7) |
| Hazard Information | Back Directory | [Uses]
Batifiban, a cyclic peptide, is a platelet glycoprotein GPⅡb/Ⅲa antagonist, and inhibits platelet aggregation. Batifiban blocks circulating vitronectin binding to integrin ανβ3, Batifiban can be used for research of acute coronary syndromes[1]. | [References]
[1] Chen H, et al. Safety, pharmacokinetic and pharmacodynamic studies of batifiban injection following single- and multiple-dose administration to healthy Chinese subjects. J Huazhong Univ Sci Technolog Med Sci. 2009 Feb;29(1):12-8. DOI:10.1007/s11596-009-0103-7 |
|
| Company Name: |
Fuan Bio
|
| Tel: |
15002819872 |
| Website: |
fuanbio.com |
|